Cervical cancer screening using the Cervista high-risk human papillomavirus test: opportunistic screening of a hospital-based population in Fujian province, China

OBJECTIVES: The Cervista(®) high-risk human papillomavirus (HR-HPV) test was evaluated as a primary screening method for cervical cancer in women aged ≥21 years and was compared with different screening and triage combinations. MATERIALS AND METHODS: A nested case–control study within the Fujian pro...

Descripción completa

Detalles Bibliográficos
Autores principales: Ruan, Guanyu, Song, Yiyi, Dong, Binhua, Mao, Xiaodan, Lin, Fen, Kang, Yafang, Xu, Shuxia, Chen, Xianjing, Wu, Qibin, Sun, Pengming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6130297/
https://www.ncbi.nlm.nih.gov/pubmed/30233239
http://dx.doi.org/10.2147/CMAR.S169822

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6130297/
https://www.ncbi.nlm.nih.gov/pubmed/30233239
http://dx.doi.org/10.2147/CMAR.S169822

Ejemplares similares